The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

By targeting a previously unexploited metabolic pathway essential for bacterial survival, the drug candidate may offer the potential to develop safer, shorter and more effective treatment regimens ...

A new credit card-sized tuberculosis (TB) test, requiring no electricity, could revolutionize detection in HIV hotspots by ...

Priyanka Sharma 3 min read 24 Jun 2025, 03:26 PM IST ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

In 2018, about 3.2 million women worldwide contracted tuberculosis (TB) and almost 500 000 died from the disease. 1 Although TB affects more men than women, it disproportionally places women at a ...

Anyone who attended St. Michael’s Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

Anyone who attended St. Michael's Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Barack Odima is two years into treatment, relying on a rare drug for extensively drug-resistant tuberculosis. It vanished from stock at the clinic he uses, in the weeks after the U.S. funding freeze.

In 2023, roughly 10.8 million people had TB globally, leading to 1.25 million deaths, WHO reported, and just two in five people with resistant TB received treatment that year.

Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms. However, new research offers fresh hope ...